A dose‐ranging study of the efficacy and safety of tamsulosin, the first prostate‐selective &agr; <sub>1A</sub> ‐adrenoceptor antagonist*, in patients with benign prostatic obstruction - Concepedia

Concepedia

Publication | Closed Access

A dose‐ranging study of the efficacy and safety of tamsulosin, the first prostate‐selective &agr; <sub>1A</sub> ‐adrenoceptor antagonist*, in patients with benign prostatic obstruction

109

Citations

0

References

1997

Year

Paul Abrams, Mark Speakman, M. STOTT, D. G. ARKELL, Richard Pocock

British Journal of Urology

Abstract

Tamsulosin is well tolerated and effective in improving urinary flow and relieving LUTS associated with BPO. Optimal effects are achieved with tamsulosin 0.4 mg administered once daily.